Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease [5]

American Journal of Gastroenterology

Volumn 97, Issue 2, 2002, Pages 490-491

  Papa, Alfredo ^a,b   Danese, Silvio ^a   Gasbarrini, Giovanni ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

CYANOCOBALAMIN DEFICIENCY; ENTERITIS; ENZYME DEFECT; FOLIC ACID DEFICIENCY; GENE MUTATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; LETTER; MAJOR CLINICAL STUDY; METABOLISM; METHYLATION; NUTRITIONAL DEFICIENCY; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 0036180931     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04068-0     Document Type: Letter

References (5)

1. Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study
2. Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?
3. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels
4. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenetic link with thromboembolic complications?
5. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations